126 Exploring Real-World Treatment Patterns and Outcomes in Stage IIIA N2 Non-Small Cell Lung Cancer (NSCLC)

Stage IIIA N2 NSCLC presents a significant clinical challenge, with suboptimal survival rates despite therapeutic advancements, highlighting the need for more effective treatments.

Source: Lung Cancer - April 1, 2024 Category: Cancer & Oncology Authors: Eleni Josephides, Roberta Dunn, Mona Faranghi, Annie-Rose Henry, John Pilling, Karen Harrison-Phipps, Shahreen Ahmad, Michael Skwarski, Benjamin Taylor, James Spicer, Alexandros Georgiou, Sharmistha Ghosh, George Santis, Ronan Breen, Mieke Van Hemelrijck, Tags: Other Source Type: research